Latest Insider Transactions at Syndax Pharmaceuticals Inc (SNDX)
This section provides a real-time view of insider transactions for Syndax Pharmaceuticals Inc (SNDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syndax Pharmaceuticals Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syndax Pharmaceuticals Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2023
|
William Meury |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 02
2023
|
Martin H. Huber Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+33.33%
|
-
|
|
Feb 02
2023
|
Dennis Podlesak |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+22.9%
|
-
|
|
Feb 02
2023
|
Jennifer Jarrett |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 02
2023
|
Keith Katkin |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 02
2023
|
Pierre Legault |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 01
2023
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
69
-100.0%
|
$1,932
$28.43 P/Share
|
|
Jan 31
2023
|
Peter Ordentlich Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
69
+50.0%
|
$1,173
$17.32 P/Share
|
|
Jan 13
2023
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
15,000
-18.66%
|
$405,000
$27.0 P/Share
|
|
Jan 13
2023
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+15.57%
|
$195,000
$13.58 P/Share
|
|
Jan 12
2023
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
24,000
-42.86%
|
$624,000
$26.74 P/Share
|
|
Jan 12
2023
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+30.0%
|
$216,000
$9.47 P/Share
|
|
Dec 02
2022
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
17,200
-98.48%
|
$430,000
$25.05 P/Share
|
|
Dec 02
2022
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,200
+49.62%
|
$103,200
$6.38 P/Share
|
|
Dec 01
2022
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,800
-93.63%
|
$195,000
$25.01 P/Share
|
|
Dec 01
2022
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,800
+48.36%
|
$46,800
$6.37 P/Share
|
|
Oct 06
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,231
-47.89%
|
$405,775
$25.29 P/Share
|
|
Oct 06
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,231
+32.38%
|
$129,848
$8.77 P/Share
|
|
Oct 06
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
29,899
-30.77%
|
$747,475
$25.9 P/Share
|
|
Oct 06
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
29,899
+23.2%
|
$239,192
$8.41 P/Share
|
|
Oct 04
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,280
-6.76%
|
$32,000
$25.02 P/Share
|
|
Oct 04
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,280
+6.33%
|
$10,240
$8.77 P/Share
|
|
Oct 04
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
360
-0.56%
|
$9,000
$25.0 P/Share
|
|
Oct 04
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
360
+0.56%
|
$2,880
$8.41 P/Share
|
|
Oct 03
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,883
-14.03%
|
$72,075
$25.01 P/Share
|
|
Oct 03
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,883
+12.31%
|
$23,064
$8.77 P/Share
|
|
Oct 03
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
180
-0.28%
|
$4,500
$25.0 P/Share
|
|
Oct 03
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
180
+0.28%
|
$1,440
$8.41 P/Share
|
|
Sep 30
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,606
-62.64%
|
$740,150
$25.02 P/Share
|
|
Sep 30
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,606
+38.51%
|
$236,848
$8.77 P/Share
|
|
Sep 30
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
3,561
-5.16%
|
$89,025
$25.07 P/Share
|
|
Sep 30
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
3,561
+4.82%
|
$28,488
$8.41 P/Share
|
|
Sep 20
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
59,649
-76.98%
|
$1,371,927
$23.25 P/Share
|
|
Sep 20
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
59,649
+43.5%
|
$596,490
$10.9 P/Share
|
|
Sep 19
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
114,339
-86.51%
|
$2,629,797
$23.03 P/Share
|
|
Sep 19
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
114,339
+46.38%
|
$1,143,390
$10.9 P/Share
|
|
Sep 16
2022
|
Dennis Podlesak |
SELL
Open market or private sale
|
Direct |
11,975
-7.32%
|
$275,425
$23.43 P/Share
|
|
Sep 16
2022
|
Dennis Podlesak |
BUY
Exercise of conversion of derivative security
|
Direct |
11,975
+6.82%
|
$71,850
$6.34 P/Share
|
|
Sep 16
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
125,000
-77.49%
|
$2,875,000
$23.22 P/Share
|
|
Sep 16
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+43.64%
|
$1,125,000
$9.05 P/Share
|
|
Sep 15
2022
|
Dennis Podlesak |
SELL
Open market or private sale
|
Direct |
66,840
-46.87%
|
$1,604,160
$24.2 P/Share
|
|
Sep 15
2022
|
Dennis Podlesak |
BUY
Exercise of conversion of derivative security
|
Direct |
66,840
+31.91%
|
$401,040
$6.32 P/Share
|
|
Sep 15
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
66,775
-78.92%
|
$1,602,600
$24.2 P/Share
|
|
Sep 15
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
66,775
+44.11%
|
$467,425
$7.2 P/Share
|
|
Sep 14
2022
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
87,645
-83.09%
|
$2,015,835
$23.8 P/Share
|
|
Sep 14
2022
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
87,645
+45.38%
|
$613,515
$7.2 P/Share
|
|
Aug 24
2022
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-93.95%
|
$625,000
$25.04 P/Share
|
|
Aug 24
2022
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.41%
|
$150,000
$6.34 P/Share
|
|
Aug 05
2022
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
24,000
-27.12%
|
$552,000
$23.02 P/Share
|
|
Aug 05
2022
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+21.28%
|
$216,000
$9.28 P/Share
|